Cargando…

Editorial: The developments of metal-based agents against lung cancer

Detalles Bibliográficos
Autores principales:	Gou, Yi, Liu, Li, Liang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773868/ https://www.ncbi.nlm.nih.gov/pubmed/36569321 http://dx.doi.org/10.3389/fphar.2022.1101890

Ejemplares similares

Advances in thiosemicarbazone metal complexes as anti-lung cancer agents
por: Bai, Xian-Guang, et al.
Publicado: (2022)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
por: Zhou, Fanfan, et al.
Publicado: (2022)

Editorial: Nature Inspired Protective Agents Against Oxidative Stress
por: Oliverio, Manuela, et al.
Publicado: (2022)

Editorial: Model-Based Evaluation of Antimicrobial Agents in Children
por: Zhao, Wei, et al.
Publicado: (2021)

Editorial: Targeted Subcellular Delivery of Anti-cancer Agents
por: Jans, David A., et al.
Publicado: (2019)

Editorial: Novel small molecules in targeted cancer therapy
por: Li, Rong, et al.
Publicado: (2023)

Challenges and opportunities in the development of metal-based anticancer theranostic agents
por: Vaidya, Shreyas P., et al.
Publicado: (2022)

Natural Products-Based Metallic Nanoparticles as Antimicrobial Agents
por: Susanti, Deny, et al.
Publicado: (2022)

Editorial: Protein-based nanocarriers for delivery of nutraceutical, diagnostic and therapeutic agents
por: Zhong, Jian, et al.
Publicado: (2022)

Editorial: Model-based evaluation of antimicrobial agents in children—volume II
por: Zhao, Wei, et al.
Publicado: (2023)

Editorial: Curcuminoids: their pleiotropism against hallmarks of cancers
por: Pouliquen, Daniel L., et al.
Publicado: (2023)

1,2,3-Triazole-Containing Compounds as Anti–Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure–Activity Relationship
por: Liang, Ting, et al.
Publicado: (2021)

Editorial: Medicinal Plants and Marine-Derived Natural Products as Cancer Chemopreventive Agents
por: Ullah, Riaz, et al.
Publicado: (2022)

Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma
por: Luo, Yi, et al.
Publicado: (2020)

Editorial: Delivery of Locally-Acting Agents to Intracellular Targets
por: Rosenkranz, Andrey A., et al.
Publicado: (2020)

Editorial: Anti-cancer effects of natural products against reproductive cancers
por: Ribeiro, Rosy Iara Maciel Azambuja, et al.
Publicado: (2023)

Editorial: Natural products, medicinal foods and complementary and alternative medicine as cancer-preventive agents
por: Zia-Ul-Haq, Muhammad, et al.
Publicado: (2023)

Editorial: Plant-based drugs: the potential novel therapeutic intervention against cancer stemness and metastasis
por: Liju, Vijayasteltar B., et al.
Publicado: (2023)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Editorial: Exploring the therapeutic effects of synthetic, semi-synthetic and naturally derived compounds against cancer
por: Feng, Liang, et al.
Publicado: (2023)

Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents
por: Lushchekina, Sofya V., et al.
Publicado: (2018)

Editorial: Inspired by Nature: Towards Novel Anti-Infective Agents
por: Ferreira, Ricardo J., et al.
Publicado: (2022)

Editorial: Lymphatic delivery and targeting of drugs, vaccines, and imaging agents
por: Han, Sifei, et al.
Publicado: (2022)

Current status of iridium-based complexes against lung cancer
por: Yang, Tongfu, et al.
Publicado: (2022)

Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
por: Mondal, Priya, et al.
Publicado: (2023)

Cinobufagin Is a Selective Anti-Cancer Agent against Tumors with EGFR Amplification and PTEN Deletion
por: He, Kunyan, et al.
Publicado: (2021)

Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis
por: Li, Wen-Qing, et al.
Publicado: (2022)

Resveratrol—Potential Antibacterial Agent against Foodborne Pathogens
por: Ma, Dexter S. L., et al.
Publicado: (2018)

Editorial: Model-informed drug development and evidence-based translational pharmacology
por: Zhao, Jinxin, et al.
Publicado: (2022)

Editorial: New Therapeutic Approaches Against Inflammation and Immune Regulation in Metabolic Related Diseases
por: Lu, Yao, et al.
Publicado: (2022)

Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV
por: von Kleist, Max, et al.
Publicado: (2020)

Editorial: Establishing Genetic Pleiotropy to Identify Common Pharmacological Agents for Common Diseases
por: O’Mara, Tracy A., et al.
Publicado: (2019)

Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
por: Wang, Yan, et al.
Publicado: (2023)

Editorial: Chemosensitizing effect of natural products against cancers: Applications in enhancing chemotherapy and immunotherapy
por: Roy, Nand K., et al.
Publicado: (2022)

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease
por: Li, Xiao, et al.
Publicado: (2023)

Editorial: Molecular Mechanisms Protecting against Tissue Injury
por: Wagener, Frank A. D. T. G., et al.
Publicado: (2016)

Editorial: Toxicity Mechanisms, Exposure, Toxicokinetic and Risk Assessment Aspects of Metals, Toxic for Animals and Humans
por: Zhu, Yanzhu, et al.
Publicado: (2022)

Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
por: Rijo, Patricia, et al.
Publicado: (2022)

Editorial: Anti-Inflammatory Agents in the Context of Age-Related Cardiometabolic Disease: Ethnopharmacological Perspectives
por: Arumugam, Somasundaram, et al.
Publicado: (2022)

Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models
por: Lam, Sze-Kwan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lqg9vbqb3bvq73fdqmiege06n8